OssDsign Q1: A slowdown in sales but case intact

Research Note

2021-04-19

16:32

Redeye comments on OssDsign’s Q1 report and continues to have a positive view on the case, despite a decrease in sales as US vaccine rollouts accelerate and its cash position is refuelled.

OB

Oscar Bergman

Disclosures and disclaimers

Premium Plan required to unlock

Unlock companies to access

more high quality research.